GPR55 and squamous cell carcinoma: However, the involvement of endocannabinoids in carcinogenesis and the druggability of GPR55 as a target for the treatment of squamous cell carcinoma were not investigated in this study, as this would require a pharmacological experimental approach with GPR55-inhibiting cannabinoids.